Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 8, 2015, Pages 1631-1637

  Akhloufi, H ^a   Streefkerk, R H ^a   Melles, D C ^a   de Steenwinkel, J E M ^a   Schurink, C A M ^a   Verkooijen, R P ^a   van der Hoeven, C P ^a   Verbon, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; GLYCOPEPTIDE; MACROLIDE; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; QUINOLONE DERIVATIVE; SULFONAMIDE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; DEMOGRAPHY; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH CARE POLICY; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RESPIRATORY TRACT INFECTION; STANDARDIZATION; TERTIARY CARE CENTER; TREATMENT DURATION; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; WARD; CLINICAL PRACTICE; COMMUNICABLE DISEASES; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MIDDLE AGED; NETHERLANDS; PRACTICE PATTERNS, PHYSICIANS'; TERTIARY CARE CENTERS;

EID: 84937970909     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2398-6     Document Type: Article

References (30)

1. de Kraker ME, Davey PG, Grundmann H; BURDEN study group (2011) Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 8(10):e1001104
2. US Centers for Disease Control and Prevention (CDC) (2013) Antibiotic resistance threats in the United States, 2013. Available online at: http://www.cdc.gov/drugresistance/threat-report-2013/
3. European Antimicrobial Resistance Surveillance Network (EARSS) (2009) EARSS annual report 2008: on-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. Available online at: http://www.nsih.be/ears-net/downloads1/2008_EARSS_Annual_Report.pdf
4. NETHMAP/MARAN (2013) Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2012. Available online at: http://www.wageningenur.nl/upload_mm/7/8/9/52388c6c-858c-483c-b57d-227029fe778a_005738_Nethmap_2013%20def_web.pdf. Cited 26 July 2013
5. Mouton RP, Glerum JH, van Loenen AC (1976) Relationship between antibiotic consumption and frequency of antibiotic resistance of four pathogens—a seven-year survey. J Antimicrob Chemother 2(1):9–19
6. Kerremans JJ, Verbrugh HA, Vos MC (2012) Frequency of microbiologically correct antibiotic therapy increased by infectious disease consultations and microbiological results. J Clin Microbiol 50(6):2066–2068
7. Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J (2007) Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother 51(3):864–867
8. Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W, Verbrugh HA, Vos MC (2008) Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother 61(2):428–435
9. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44(2):159–177
10. Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N (2011) Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 66(6):1223–1230
11. Elligsen M, Walker SA, Pinto R, Simor A, Mubareka S, Rachlis A, Allen V, Daneman N (2012) Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis. Infect Control Hosp Epidemiol 33(4):354–361
12. Palmay L, Elligsen M, Walker SA, Pinto R, Walker S, Einarson T, Simor A, Rachlis A, Mubareka S, Daneman N (2014) Hospital-wide rollout of antimicrobial stewardship: a stepped-wedge randomized trial. Clin Infect Dis 59(6):867–874
13. Streefkerk RH, Moorman PW, Parlevliet GA, van der Hoeven C, Verbrugh HA, Vos MC, Verkooijen RP (2014) An automated algorithm to preselect patients to be assessed individually in point prevalence surveys for hospital-acquired infections in surgery. Infect Control Hosp Epidemiol 35(7):886–887
14. Streefkerk RH, Borsboom GJ, van der Hoeven CP, Vos MC, Verkooijen RP, Verbrugh HA (2014) Evaluation of an algorithm for electronic surveillance of hospital-acquired infections yielding serial weekly point prevalence scores. Infect Control Hosp Epidemiol 35(7):888–890
15. Gyssens IC, van den Broek PJ, Kullberg BJ, Hekster Y, van der Meer JW (1992) Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation. J Antimicrob Chemother 30(5):724–727
16. Ingram PR, Seet JM, Budgeon CA, Murray R (2012) Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital. Intern Med J 42(6):719–721
17. Drusano GL (1998) Infection in the intensive care unit: beta-lactamase-mediated resistance among Enterobacteriaceae and optimal antimicrobial dosing. Clin Infect Dis 27(Suppl 1):S111–S116
18. Thomas JK, Forrest A, Bhavnani SM, Hyatt JM, Cheng A, Ballow CH, Schentag JJ (1998) Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 42(3):521–527
19. European Centre for Disease Prevention and Control (ECDC) (2010) Surveillance report. Antimicrobial resistance surveillance in Europe 2009. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm. Available online at: http://ecdc.europa.eu/en/publications/publications/1011_sur_annual_ears_net_2009.pdf
20. Swindell PJ, Reeves DS, Bullock DW, Davies AJ, Spence CE (1983) Audits of antibiotic prescribing in a Bristol hospital. Br Med J (Clin Res Ed) 286(6359):118–122
21. Gyssens IC, Geerligs IE, Nannini-Bergman MG, Knape JT, Hekster YA, van der Meer JW (1996) Optimizing the timing of antimicrobial prophylaxis in surgery: an intervention study. J Antimicrob Chemother 38(2):301–308
22. Gyssens IC, Blok WL, van den Broek PJ, Hekster YA, van der Meer JW (1997) Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine. Eur J Clin Microbiol Infect Dis 16(12):904–912
23. Kunin CM, Tupasi T, Craig WA (1973) Use of antibiotics. A brief exposition of the problem and some tentative solutions. Ann Intern Med 79(4):555–560
24. Maki DG, Schuna AA (1978) A study of antimicrobial misuse in a university hospital. Am J Med Sci 275(3):271–282
25. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, Ramsay CR, Wiffen PJ, Wilcox M (2013) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 4:CD003543
26. Hunt DL, Haynes RB, Hanna SE, Smith K (1998) Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA 280(15):1339–1346
27. Shojania KG, Yokoe D, Platt R, Fiskio J, Ma’luf N, Bates DW (1998) Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc 5(6):554–562
28. Madaras-Kelly KJ, Remington RE, Lewis PG, Stevens DL (2006) Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 27(2):155–169
29. Hulgan T, Rosenbloom ST, Hargrove F, Talbert DA, Arbogast PG, Bansal P, Miller RA, Kernodle DS (2004) Oral quinolones in hospitalized patients: an evaluation of a computerized decision support intervention. J Intern Med 256(4):349–357
30. Paul M, Andreassen S, Tacconelli E, Nielsen AD, Almanasreh N, Frank U, Cauda R, Leibovici L; TREAT Study Group (2006) Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother 58(6):1238–1245